Longboard Pharmaceuticals... (LBPH)
59.98
null (null%)
At close: Nov 29, 2024, 6:00 PM
Company Description
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases.
The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies.
Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases.
The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020.
Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.
Longboard Pharmaceuticals Inc.
| Country | United States |
| IPO Date | Mar 12, 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 50 |
| CEO | Kevin R. Lind |
Contact Details
Address: 4275 Executive Square La Jolla, California United States | |
| Website | https://www.longboardpharma.com |
Stock Details
| Ticker Symbol | LBPH |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001832168 |
| CUSIP Number | 54300N103 |
| ISIN Number | US54300N1037 |
| Employer ID | 84-5009619 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Kevin R. Lind | President, Chief Executive Officer, Secretary & Director |
| Brandi L. Roberts CPA, M.B.A. | Executive Vice President & Chief Financial Officer |
| Chadwick J. Orevillo MPH | Executive Vice President & Head of Operations |
| Dr. Randall E. Kaye M.D. | Executive Vice President & Chief Medical Officer |
| Steven W. Spector J.D. | Executive Vice President, Head of Business Development & General Counsel |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Feb 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Feb 11, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Dec 12, 2024 | 15-12G | Filing |
| Dec 10, 2024 | POSASR | Filing |
| Dec 10, 2024 | RW WD | Filing |
| Dec 02, 2024 | 4 | Filing |
| Dec 02, 2024 | 4 | Filing |
| Dec 02, 2024 | 4 | Filing |
| Dec 02, 2024 | 4 | Filing |